CP 571 75 mg Pill - brown & white capsule/oblong, 18mm
Pill with imprint CP 571 75 mg is Brown & White, Capsule/Oblong and has been identified as Doxycycline Monohydrate 75 mg.
Doxycycline is used in the treatment of Acne; Actinomycosis; Amebiasis; Anthrax; Ocular Rosacea and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CP 571 75 mg
Doxycycline Monohydrate
- Imprint
- CP 571 75 mg
- Strength
- 75 mg
- Color
- Brown & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Cosette Pharmaceuticals Inc
- National Drug Code (NDC)
- 00713-0571
- Inactive Ingredients
-
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin,
sodium lauryl sulfate,
shellac,
potassium hydroxide,
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,624)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
- Doxycycline drug information
- Doxycycline Delayed-Release Tablets
- Doxycycline Tablets and Capsules
- Doxycycline Capsules (Rosacea)
- Doxycycline Syrup
Other brands
Vibramycin, Monodox, Doxy 100, Doryx, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doxy 100, Doryx, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.